(Bloomberg) -- Kimberly-Clark Corp.’s potential sale of its international tissue business has attracted interest from companies including Royal Golden Eagle Pte, Brazil’s Suzano SA and Asia Pulp & Paper Co., according to people familiar with the situation.

The unit could be valued at about $4 billion, one of the people said, asking not to be identified discussing a private matter. Deliberations are ongoing and may not lead to a transaction, the people said. 

Representatives for Kimberly-Clark and Royal Golden Eagle declined to comment. Representatives for Suzano and Asia Pulp & Paper didn’t immediately respond to requests for comment. 

Bloomberg News reported in October that Kimberly-Clark was working with advisers to review its tissue operations outside of North America, potentially leading to a sale of part or all of the business. 

The Dallas-based company said in March it would reorganize its operations to combine its overseas consumer tissue and professional tissue businesses under a new division called International Family Care & Professional, which generates around $3.5 billion in annual sales with operating margins of about 10%.

Kimberly-Clark is set to announce its 2024 results on Jan. 28. In October, the company lowered its full-year organic sales forecast after reporting weaker-than-expected results. Organic sales, which strip out currency volatility and other items, were expected to rise 3% to 4%, down from a previous forecast for a gain in the mid-single digits.

The company’s shares have fallen 12% since then, giving Kimberly-Clark a market value of about $42 billion.

--With assistance from Vinicy Chan.

(Updates with sales forecast in sixth paragraph.)

©2025 Bloomberg L.P.